Literature DB >> 25730439

Conformational difference in human IgG2 disulfide isoforms revealed by hydrogen/deuterium exchange mass spectrometry.

Aming Zhang1, Jing Fang1, Robert Y-T Chou1, Pavel V Bondarenko1, Zhongqi Zhang1.   

Abstract

Both recombinant and natural human IgG2 antibodies have several different disulfide bond isoforms, which possess different global structures, thermal stabilities, and biological activities. A detailed mapping of the structural difference among IgG2 disulfide isoforms, however, has not been established. In this work, we employed hydrogen/deuterium exchange mass spectrometry to study the conformation of three major IgG2 disulfide isoforms known as IgG2-B, IgG2-A1, and IgG2-A2 in two recombinant human IgG2 monoclonal antibodies. By comparing the protection factors between amino acid residues in isoforms B and A1 (the classical form), we successfully identified several local regions in which the IgG2-B isoform showed more solvent protection than the IgG2-A1 isoform. On the basis of three-dimensional structural models of IgG2, these identified regions were located on the Fab domains, close to the hinge, centered on the side where the two Fab arms faced each other in spatial proximity. We speculated that in the more solvent-protected B isoform, the two Fab arms were brought into contact by the nonclassical disulfide bonds, resulting in a more compact global structure. Loss of Fab domain flexibility in IgG2-B could limit its ability to access cell-surface epitopes, leading to reduced antigen binding potency. The A2 isoform was previously found to have disulfide linkages similar to those of the classical A1 isoform, but with different biophysical behaviors. Our data indicated that, compared to IgG2-A1, IgG2-A2 had less solvent protection in some heavy-chain Fab regions close the hinge, suggesting that the A2 isoform had more flexible Fab domains.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25730439     DOI: 10.1021/bi5015216

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

Review 1.  Strategies and challenges for the next generation of antibody-drug conjugates.

Authors:  Alain Beck; Liliane Goetsch; Charles Dumontet; Nathalie Corvaïa
Journal:  Nat Rev Drug Discov       Date:  2017-03-17       Impact factor: 84.694

2.  Evidence of disulfide bond scrambling during production of an antibody-drug conjugate.

Authors:  Lily Pei-Yao Liu-Shin; Adam Fung; Arun Malhotra; Gayathri Ratnaswamy
Journal:  MAbs       Date:  2018-10-19       Impact factor: 5.857

3.  Covalent Labeling/Mass Spectrometry of Monoclonal Antibodies with Diethylpyrocarbonate: Reaction Kinetics for Ensuring Protein Structural Integrity.

Authors:  Patanachai K Limpikirati; Bo Zhao; Xiao Pan; Stephen J Eyles; Richard W Vachet
Journal:  J Am Soc Mass Spectrom       Date:  2020-04-30       Impact factor: 3.109

4.  Epitope characterization of anti-JAM-A antibodies using orthogonal mass spectrometry and surface plasmon resonance approaches.

Authors:  Guillaume Terral; Thierry Champion; François Debaene; Olivier Colas; Maxime Bourguet; Elsa Wagner-Rousset; Nathalie Corvaia; Alain Beck; Sarah Cianferani
Journal:  MAbs       Date:  2017-09-21       Impact factor: 5.857

5.  The solution structure of the human IgG2 subclass is distinct from those for human IgG1 and IgG4 providing an explanation for their discrete functions.

Authors:  Gar Kay Hui; Antoni D Gardener; Halima Begum; Charles Eldrid; Konstantinos Thalassinos; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2019-05-14       Impact factor: 5.157

6.  Alleviating nonlinear behavior of disulfide isoforms in the reversed-phase liquid chromatography of IgG2.

Authors:  Xiang Cao; Yan He; Jacquelynn Smith; Mary J Wirth
Journal:  J Chromatogr A       Date:  2015-08-04       Impact factor: 4.759

7.  Disulfide Bond Characterization of Endogenous IgG3 Monoclonal Antibodies Using LC-MS: An Investigation of IgG3 Disulfide-mediated Isoforms.

Authors:  Jude C Lakbub; Daniel F Clark; Ishan S Shah; Zhikai Zhu; Eden P Go; Thomas J Tolbert; Heather Desaire
Journal:  Anal Methods       Date:  2016-07-27       Impact factor: 2.896

8.  The effects of intramolecular and intermolecular electrostatic repulsions on the stability and aggregation of NISTmAb revealed by HDX-MS, DSC, and nanoDSF.

Authors:  Yoshitomo Hamuro; Mehabaw Getahun Derebe; Sathya Venkataramani; Jennifer F Nemeth
Journal:  Protein Sci       Date:  2021-06-23       Impact factor: 6.993

9.  Reversed-phase chromatography with large pore superficially porous particles for high throughput immunoglobulin G2 disulfide isoform separation.

Authors:  Bingchuan Wei; Bing Zhang; Barry Boyes; Yonghua Taylor Zhang
Journal:  J Chromatogr A       Date:  2017-10-18       Impact factor: 4.601

Review 10.  The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively.

Authors:  Wen-Qian Li; Han-Fei Guo; Ling-Yu Li; Yong-Fei Zhang; Jiu-Wei Cui
Journal:  Cancer Med       Date:  2021-06-24       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.